News & Updates
Filter by Specialty:

PCC does not improve outcomes for Chinese patients with DOAC-associated ICH
Prothrombin complex concentrate (PCC) treatment does not improve functional outcomes or reduce haematoma expansion or mortality in Chinese atrial fibrillation (AF) patients with direct-acting oral anticoagulant (DOAC)–associated intracerebral haemorrhage (ICH), researchers from the Chinese University of Hong Kong (CUHK) have reported.
PCC does not improve outcomes for Chinese patients with DOAC-associated ICH
30 Jul 2024
Disrupted circadian rhythm a modifiable risk factor for Alzheimer’s disease?
Circadian rhythm disruption appears to precede the accumulation of amyloid-beta plaques and potentially represents a modifiable risk factor for Alzheimer's disease (AD), according to a study.
Disrupted circadian rhythm a modifiable risk factor for Alzheimer’s disease?
28 Jul 2024
Is there a link between parental smoking, MS?
A study presented at EAN 2024 found that selective exposure to parental smoking at an early age may increase the risk of developing multiple sclerosis (MS) later in life.
Is there a link between parental smoking, MS?
24 Jul 2024
Is it safe to use conditionally ordered LMWH in cancer patients with VTE?
Conditional orders of low molecular weight heparin (LMWH) based on platelet values appears safe and effective in the treatment of venous thromboembolism (VTE) in patients with malignant haematology (MH) experiencing thrombocytopenia, a study has shown. In addition, worsening or new VTE has not been reported among study participants.
Is it safe to use conditionally ordered LMWH in cancer patients with VTE?
23 Jul 2024
Are bad dreams tied to cognitive decline, dementia in adults?
Having frequent distressing dreams may signal a higher risk of developing cognitive decline and dementia in adults, according to a prospective study of three population-based cohorts.